Female Fertility Tests/Treatments

About Heranova Lifesciences

Heranova Lifesciences is a private, early-stage diagnostics company targeting significant unmet needs in women's health. The company has launched its first commercial product, HerResolve™, a non-invasive blood test for the detection and confirmation of endometriosis, which is being rolled out at select US fertility clinics. Heranova is positioned in a large and underserved market, aiming to reduce the diagnostic delay for endometriosis and improve fertility treatment planning. The company appears to be in an early revenue-generating phase as it commercializes its initial test while developing a broader pipeline of diagnostics and potential treatments.

Therapeutic Areas